MedPath

Mobile app for cardiovascular risk modification among diabetic patients

Not Applicable
Conditions
Health Condition 1: E08-E13- Diabetes mellitus
Registration Number
CTRI/2021/12/038689
Lead Sponsor
MGM Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Diagnosed cases of Type 2 Diabetes Mellitus Aged �18 years of age

2) Patients who agree to sign the informed consent form

Exclusion Criteria

1) Patients with Type 1 diabetes mellitus

Pregnant women, including those with gestational diabetes

2) People with established coronary heart disease, cerebrovascular disease and peripheral vascular disease

�Patients who do not agree to sign consent form

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Development of a mobile app on assessment and preventive strategies (Pharmacological and Non-Pharmacological Intervention) for CVD risk modification among diabetic patients <br/ ><br> <br/ ><br>Effectiveness of mobile app based interventional tool for CVD self-management practices and risk factor reduction among diabetic patients <br/ ><br>Timepoint: 0,3 and 6 months
Secondary Outcome Measures
NameTimeMethod
1.Impact of using CVD risk prediction app on prescribing practices for Type 2 diabetic patients with variable CVD risk profiles <br/ ><br>2.Acceptability among the diabetic patients and physicians regarding usefulness of the mobile app for cardiovascular risk modification <br/ ><br>Timepoint: 0,3 and 6 months
© Copyright 2025. All Rights Reserved by MedPath